https://www.avient.com/sites/default/files/resources/PolyOne%25202013%2520Annual%2520Report.pdf
This increase was driven
primarily by organic improvements in sales and mix.
The increase is primarily due to
improvement in mix and the Spartech acquisition.
The plans generally provide benefit payments using a formula that is based upon employee
compensation and length of service.
https://www.avient.com/sites/default/files/2022-05/AVNT May IR Presentation w Non GAAP Recs.pdf
Outdoor High Performance) 8 18% 3
Growth in Asia / LATAM 6 3% 2
Other 100 19% 5
Sub-total $1,327 14% $146
Outdoor High Performance Impact (5) (3)
Wage Inflation and Overtime (11)
Other Supply Chain Costs (4)
Synergies 5
Incentives, Other Employee Costs 8
FX (28) (5)
Q1 2022 $1,294 11% $136
Q1 2022 SALES AND OPERATING INCOME
Sales Growth Rate
Operating
Income$ millions
EBITDA
Q1 EBITDA BRIDGE
12
Price increases more than
offset raw material and
supply chain impacts
Q1 2021 $ 161
Demand (23)
$ millions
CAI:
Price / Mix 77
Inflation (54)
SEM:
Price / Mix 41
Inflation (26)
Distribution:
Price / Mix 84
Inflation (82)
Net Price Benefit 40
Wage Inflation and Overtime (11)
Other Supply Chain Costs (4)
Synergies 5
Incentives, Other Employee Costs 8
FX (5)
Q1 2022 $ 171
China Lockdowns / Russia Impact $ (7)
Transportation (7)
Outdoor High Performance (3)
Q1 EPS BRIDGE
13
Q1 2021 - Adjusted EPS 0.89$
CAI 0.08
Specialty Engineered Materials 0.06
Distribution 0.00
Corporate Costs 0.02
F/X (0.04)
Segment OI 0.12
Tax Rate (0.02)
Q1 2022 - Adjusted EPS 0.99$
2022 O U T LO O K
REVENUE GROWTH DRIVERS
Growth Drivers Long-Term
Growth Rate
2022E
Growth Rate
Sustainable Solutions 8–12% 12%
Healthcare 8–10% 10%
Composites 10% 5%
Asia / LATAM 5% 5%
Other (GDP growth) 2–3% 2–3%
Avient 6.5% 6%
15
Excluding Outdoor High Performance 20%
(8% excl.
OUR VALUATION VERSUS PEERS
Avient Specialty
Other
5.4
8.5
10.1 9.8
13.8
12.8 12.1 11.8
10.2
21.0
19.2
16.8
13.7 13.6
8.8 8.7 8.7 8.3 8.0
5.6
01
1)
01
6)
02
1)
(T
od
ay
)
PM PP
AV
VR C
Historic Multiple
APPENDIX
Performance
Additives
15%
Pigments
TiO2
Dyestuffs
3%Polyethylene
Nylon
6%
Polypropylene
Other Raw
Materials
30%
Styrenic Block
Copolymer
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
48
• Significant raw material price inflation and
tight inventory continued in Q1 2022
o The average cost of hydrocarbon based
materials was up 30%
o The average cost of non-hydrocarbon based
materials was up 20%
• Additionally, we continued to experience
other supply chain challenges during Q1
related to raw material spot purchases,
freight constraints and productivity loss as
a result of these shortages
Annual Purchases
RAW MATERIAL AND SUPPLY CHAIN UPDATE
Based on 2021 purchases, excludes Distribution business
SEGMENT DATA
U.S. & Canada
50%
Latin America
2021 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
23%
19%
Building and
END MARKET REVENUE
(1) Total company sales and adjusted EBITDA of $4,819M and $581M, respectively, include intercompany sales eliminations and corporate costs
$2,402M
$409M
$919M
$164M
$1,631M
$94M
Sales EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$581M$4,819M
15%
34%
Building &
1% Telecommunications
C O L O R , A D D I T I V E S & I N K S
2021 REVENUE | $2 .4 BILLION
32%
40%
Latin America
END MARKET REGION
51
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
27%
Building &
2021 REVENUE | $919 MILLION
END MARKET
55%
REGION
52
DI S T RI BU T I O N
26%
23%
Building and
80%
3%
Latin
America
END MARKET REGION
K EY SU PPL IER S
2021 REVENUE | $1 .6 BILLION
53
TOTA L C O M PA N Y R E G I O N A L S A L E S
BY END MARKET
30%
26%Healthcare
14%
Building &
2% Energy
(16% of sales)
32%
Building &
(25% of sales)
54
19%
Building &
US &
Canada
(50% of sales)
38%
33%
Building &
LATAM
(9% of sales)
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
March 31, 2022
GAAP
Special
Adjusted
Operating Income $ 128.6 $ 7.8 $ 136.4
Income before income taxes $ 111.1 $ 7.7 $ 118.8
Income tax expense - GAAP (26.6) — (26.6)
Income tax impact of special items — (2.0) (2.0)
Tax adjustments — 1.5 1.5
Net income attributable to noncontrolling interests (0.3) — (0.3)
Net income attributable to Avient shareholders $ 84.2 $ 7.2 $ 91.4
EPS $ 0.91 0.08 $ 0.99
Weighted-average diluted shares 92.3 92.3 92.3
1
March 31, 2021
GAAP
Special
Adjusted
Operating Income $ 120.4 $ 2.4 $ 122.8
Income before income taxes $ 102.6 $ 2.4 $ 105.0
Income tax expense - GAAP (22.9) — (22.9)
Income tax impact of special items — (0.9) (0.9)
Tax adjustments — 1.1 1.1
Net income attributable to noncontrolling interests (0.4) — (0.4)
Net income attributable to Avient shareholders $ 79.3 $ 2.6 $ 81.9
EPS $ 0.86 0.03 $ 0.89
Weighted-average diluted shares 92.2 92.2 92.2
Year Ended
December 31, 2021
GAAP
Special
Adjusted
Operating income $ 381.2 $ 47.8 $ 429.0
Income from continuing operations before income taxes $ 304.6 $ 57.1 $ 361.7
Income tax expense - GAAP (74.0) — (74.0)
Income tax impact of special items — (13.0) (13.0)
Tax adjustments — 5.9 5.9
Net income attributable to noncontrolling interests 0.2 — 0.2
Net income from continuing operations attributable to Avient shareholders $ 230.8 $ 50.0 $ 280.8
EPS $ 2.51 0.54 $ 3.05
Weighted-average diluted shares 92.1 92.1 92.1
Reconciliation of EBITDA by Segment
March 31,
Year Ended
2022 2021 2021
Operating income:
Color, Additives and Inks $ 94.5 $ 88.8 $ 303.1
Specialty Engineered Materials 39.7 34.2 132.0
Distribution 24.2 24.0 93.2
Corporate and eliminations (29.8) (26.6) (147.1)
Operating income $ 128.6 $ 120.4 $ 381.2
Items below OI in Corporate:
Other income, net $ (0.6) $ 1.5 $ (1.3)
Depreciation & amortization:
Color, Additives and Inks $ 26.0 $ 27.4 $ 105.7
Specialty Engineered Materials 7.8 7.8 31.7
Distribution 0.2 0.2 0.8
Corporate and eliminations 3.8 1.7 7.7
Depreciation & Amortization $ 37.8 $ 37.1 $ 145.9
EBITDA:
Color, Additives and Inks $ 120.5 $ 116.2 $ 408.8
Specialty Engineered Materials 47.5 42.0 163.7
Distribution 24.4 24.2 94.0
Corporate and eliminations (26.0) (24.9) (140.7)
EBITDA $ 165.8 $ 159.0 $ 525.8
Reconciliation of Sales, Operating Income and EBITDA - Distribution
Year Ended
2006 2011 2016
Sales $ 732.8 $ 996.5 $ 1,071.0
Operating income 19.2 56.0 68.2
Depreciation & amortization 1.5 0.7 0.7
EBITDA $ 20.7 $ 56.7 $ 68.9
March 31,
Year Ended
December 31,
Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 2021
Net income from continuing operations – GAAP $ 84.5 $ 79.7 $ 230.6
Income tax expense 26.6 22.9 74.0
Interest expense 16.9 19.3 75.3
Depreciation and amortization from continuing operations 37.8 37.1 145.9
EBITDA $ 165.8 $ 159.0 $ 525.8
Special items, before tax 7.7 2.4 57.1
Depreciation and amortization included in special items (2.1) (0.5) (1.7)
Adjusted EBITDA $ 171.4 $ 160.9 $ 581.2
AVNT May IR Presentation.pdf
Avient Corporation �investor meetings
DISCLAIMER
Avient: Who We Are
Who we are – Vision, Strategy, Culture
What we do: material science
Sustainability for a Better Tomorrow
Slide Number 7
Slide Number 8
Slide Number 9
Slide Number 10
Q1 2022 SALES AND OPERATING INCOME�(Total Company)
Slide Number 12
Slide Number 13
Slide Number 14
Slide Number 15
Slide Number 16
Slide Number 17
Slide Number 18
Slide Number 19
FIT with Four Pillar Strategy
Dyneema® overview
Slide Number 22
Slide Number 23
Dyneema® in the Value Chain
Demand trends
Products
Avient’s Existing Composites Portfolio
Avient’s Composites Portfolio�Sales and Ebitda
Distribution Divestiture Considerations
Distribution highlights
Dyneema® Transaction Overview
Capital structure / Leverage
Two-Year Leverage Goal
Pro forma modeling
Our Specialty Journey
Acquisition History
Clariant Color Acquisition
Specialty Transformation
Culture and People
Our Specialty Journey continues
Slide Number 41
PEER COMPARISONS
Avient is asset light
High free cash flow conversion
2022 ebitda margins vs. peers
Our valuation versus peers
Slide Number 47
Slide Number 48
Slide Number 49
�2021 segment, end market and Geography
Slide Number 51
Slide Number 52
Slide Number 53
Slide Number 54
Masseto IR Presentation - 4.19 645pm w Non GAAP Recs.pdf
Masseto IR Presentation - 4.19 (515pm) - with attachments.pdf
https://www.avient.com/sites/default/files/resources/AquaMix-_Fact_Sheet__72831-B_%25281%2529.pdf
It is highly recommended that these materials
be thoroughly mixed prior to use.
Used mainly in varnishes, inks, and adhesives,
where its hardness, resistance to aging, solubility, and inherent
adhesiveness are desirable properties.
It is highly recommended that these materials
be thoroughly mixed prior to use.
https://www.avient.com/resources/safety-data-sheets?page=3895
Geon(TM) MB2929 Backing Mix NP 3335
Geon(TM) MB2928 Backing Mix NP LC 3335
https://www.avient.com/resources/safety-data-sheets?page=1386
MIXING RED
COATES MIXING BLUE (G/S)
https://www.avient.com/sites/default/files/2025-01/Securities Trading Policy %282024%29 Final.pdf
In general, information is “material” if there is a substantial likelihood that a
reasonable investor would consider it important in making a decision to purchase, sell or
hold the securities of the company in question; would significantly affect the total mix of
information available to the public; or would likely affect the market price of a
company’s securities.
Arrangements under the rule may
specify amount, price and date through a formula or may specify trading parameters
which another person has discretion to administer, but you must not exercise any
subsequent discretion affecting the transactions, and if your broker or any other person
exercises discretion in implementing the trades, you must not influence his or her actions
and he or she must not possess any material nonpublic information at the time of the
trades.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-industrialfabricyarn.pdf
Product ID
Coating
Base Fiber
Nominal
Break Strength
Nominal Yield Description
G675/Colors
Colorcoat™
E-Glass 60 LBs (27 KGs)
1897 FT/LB
(1274 M/KG)
Color formula designed to be compatible
with customer specific resin matrix
K1420
Flamecoat™
Kevlar® 65 LBs (29 KGs)
6872 FT/LB
(4616 M/KG)
Flame retardant coating
suppresses flame and smoke
K1500
Protexcoat™
Colorcoat™
Kevlar® 69 LBs (31 KGs)
8770 FT/LB
(5892 M/KG)
Kevlar® coated with UV inhibitors and
carbon black pigment for UV protection
K14200
Repelcoat™
Kevlar® 650 LBs (294 KGs)
877 FT/LB
(588 M/KG)
Water repellant coating used in
ballistic fabric applications
V3000T N/A Vectran® 195 LBs (88 KGs)
4390 FT/LB
(2950 M/KG)
Twisted to improve processing
POPULAR INDUSTRIAL FABRIC YARN PRODUCTS
LOCATIONS
Headquarters, R&D, Manufacturing
FIBER-LINE® LLC
3050 Campus Drive
Hatfield, PA 19440
+1 215.997.9181
fiber@fiber-line.com
Manufacturing Operations
FIBER-LINE® LLC
280 Performance Drive SE
Hickory, NC 28602
+1 828.326.8700
fiber@fiber-line.com
EMEA & Asia Pacific Operations
FIBER-LINE® INTERNATIONAL B.V.
https://www.avient.com/sites/default/files/2020-09/grips-translation-outdoor-application-bulletin.pdf
Some TPE formulas produce a more
secure grip, or you can make use of a custom texture
for improved handling.
https://www.avient.com/industries/packaging/personal-care-packaging/sun-care
In addition to convenience, consumers want assurance of secure sun care products, and packaging needs to deliver UV protection for sensitive formulas coupled with high chemical resistance.
ColorMatrix™ Liquid Color Concentrates achieved the optimal flowability of liquid white and liquid orange, ensuring consistent color through suitable mixing with other colorants
https://www.avient.com/sites/default/files/2022-02/Sustainability ESG Disclosures_Silicon Dioxide.pdf
CATEGORY DETAIL
EC Number 231-545-4
CAS Number 7631-86-9
Chemical Name Silicon Dioxide (SiO2)
Structural Formula
CHEMICAL IDENTITY
Si
O O
HEALTH EFFECTS
HUMAN HEALTH SAFETY ASSESSMENT
Consumer No human health hazard has been identified relating to this substance.